- Home
- RCUS vs GSL Comparison
RCUS vs GSL Comparison
Compare RCUS & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- GSL
- Stock Information
- Founded
- RCUS 2015
- GSL 2007
- Country
- RCUS United States
- GSL Greece
- Employees
- RCUS N/A
- GSL N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- GSL Marine Transportation
- Sector
- RCUS Health Care
- GSL Consumer Discretionary
- Exchange
- RCUS Nasdaq
- GSL Nasdaq
- Market Cap
- RCUS 906.4M
- GSL 972.2M
- IPO Year
- RCUS 2018
- GSL 2006
- Fundamental
- Price
- RCUS $9.32
- GSL $28.65
- Analyst Decision
- RCUS Buy
- GSL Strong Buy
- Analyst Count
- RCUS 8
- GSL 1
- Target Price
- RCUS $20.86
- GSL $30.00
- AVG Volume (30 Days)
- RCUS 721.6K
- GSL 305.6K
- Earning Date
- RCUS 08-07-2025
- GSL 08-05-2025
- Dividend Yield
- RCUS N/A
- GSL 7.23%
- EPS Growth
- RCUS N/A
- GSL 20.64
- EPS
- RCUS N/A
- GSL 10.54
- Revenue
- RCUS $141,000,000.00
- GSL $715,232,000.00
- Revenue This Year
- RCUS N/A
- GSL $4.15
- Revenue Next Year
- RCUS $28.73
- GSL N/A
- P/E Ratio
- RCUS N/A
- GSL $2.76
- Revenue Growth
- RCUS N/A
- GSL 3.83
- 52 Week Low
- RCUS $6.50
- GSL $17.73
- 52 Week High
- RCUS $18.98
- GSL $29.23
- Technical
- Relative Strength Index (RSI)
- RCUS 55.03
- GSL 66.59
- Support Level
- RCUS $9.14
- GSL $28.71
- Resistance Level
- RCUS $10.34
- GSL $29.14
- Average True Range (ATR)
- RCUS 0.48
- GSL 0.46
- MACD
- RCUS 0.07
- GSL 0.04
- Stochastic Oscillator
- RCUS 48.91
- GSL 82.27
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.